N.E.W. Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$710K Sell
2,820
-51
-2% -$11K 0.05% 126
2026
Q1
$624K Buy
2,871
+133
+5% +$29.5K 0.05% 127
2025
Q4
$626K Buy
2,738
+19
+0.7% +$4.33K 0.05% 123
2025
Q3
$630K Buy
2,719
+1
+0% +$204 0.06% 110
2025
Q2
$504K Sell
2,718
-781
-22% -$145K 0.05% 113
2025
Q1
$733K Buy
3,499
+623
+22% +$121K 0.06% 104
2024
Q4
$511K Sell
2,876
-23
-0.8% -$4.23K 0.05% 113
2024
Q3
$573K Buy
2,899
+4
+0.1% +$747 0.06% 101
2024
Q2
$497K Sell
2,895
-1,096
-27% -$182K 0.05% 101
2024
Q1
$727K Buy
3,991
+275
+7% +$47.4K 0.08% 86
2023
Q4
$576K Buy
3,716
+451
+14% +$65.8K 0.07% 93
2023
Q3
$487K Buy
3,265
+1,617
+98% +$237K 0.07% 95
2023
Q2
$222K Buy
1,648
+3
+0.2% +$440 0.03% 124
2023
Q1
$262K Buy
1,645
+2
+0.1% +$306 0.04% 112
2022
Q4
$266K Buy
1,643
+17
+1% +$2.61K 0.04% 109
2022
Q3
$218K Buy
1,626
+102
+7% +$14.6K 0.04% 122
2022
Q2
$233K Buy
+1,524
New +$233K 0.04% 118
2022
Q1
Sell
-1,519
Closed -$206K 138
2021
Q4
$206K Buy
+1,519
New +$179K 0.03% 129

Other funds holding ABBV

N.E.W. Advisory Services's ABBV Position: Q2 2026 in Review

N.E.W. Advisory Services reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $11K and leaving 2,820 shares worth $710K. The position accounts for 0.05% of the portfolio, ranked #126.

N.E.W. Advisory Services first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $733K in Q1 2025. 2,739 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • N.E.W. Advisory Services held 2,820 shares of AbbVie worth $710K as of Q2 2026.
  • N.E.W. Advisory Services sold 51 AbbVie shares in Q2 2026, an estimated $11K.
  • AbbVie made up 0.05% of N.E.W. Advisory Services's portfolio in Q2 2026, its #126 holding.
  • N.E.W. Advisory Services first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • N.E.W. Advisory Services's AbbVie position peaked at $733K in Q1 2025.
  • 2,739 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.